Determination of butyrylcholinesterase (BChE) phenotypes to predict the risk of prolonged apnea in persons receiving succinylcholine in the healthy population of western Iran

Clinical Biochemistry

Volumn 40, Issue 9-10, 2007, Pages 629-633

  Vaisi Raygani, Asad ^a,d   Rahimi, Zohreh ^a,b,d   Kharazi, Hadi ^a,d   Tavilani, Haidar ^a,c,d   Aminiani, Mahdi ^a,c,d   Kiani, Amir ^b,d   Vaisi Raygani, Aliakbar ^a,d   Pourmotabbed, Tayebeh ^d,e  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Apnea; Butyrylcholinesterase; Dibucaine number; Fluoride number; Genotyping; Ro2 number; Succinylcholine

Indexed keywords

ANESTHETIC AGENT; CHOLINESTERASE; CINCHOCAINE; FLUORIDE; MIVACURIUM; RO 2 0683; SUXAMETHONIUM; UNCLASSIFIED DRUG;

ADULT; APNEA; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; FEMALE; GENE FREQUENCY; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; APNEA; BUTYRYLCHOLINESTERASE; FEMALE; HUMANS; IRAN; MALE; RISK; SUCCINYLCHOLINE;

EID: 34249703549     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.01.018     Document Type: Article

References (31)

1. La Du B.N., Bartels C.F., Nogueira C.P., Arpagaus O., and Lockridge M. Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing. Cell. Mol. Neurobiol. 11 (1991) 79-89
2. Kalow W. Human pharmacogenomics: the development of a science. Hum. Genomics 1 5 (2004) 375-380
3. Kalow W. Pharmacogenetics of drug metabolism (1992), Pergamon Press, New York 1-22
4. Lockridge O., and Masson P. Pesticides and susceptible populations: people with butyrylcholinesterase genetic variants may be at risk. Neurotoxicology 21 1-2 (2000) 113-126
5. Brock A., and Brock V. Factors affecting inter-individual variation in human plasma cholinesterase activity: body weight, height, sex, polymorphism and age. Arch. Environ. Contam. Toxicol. 24 (1992) 93-99
6. Evans R.T. Cholinesterase phenotyping: clinical aspects and laboratory applications. CRS Crit. Rev. Clin. Lab. Sci. 23 (1986) 35-64
7. Jensen F.S., Bartels C.F., and La Du B.N. Structural basis of the butyrylcholinesterase H-variant segregating in two Danish families. Pharmacogenetics 2 5 (1992) 234-240
8. Whittaker M. In: Backman Karger L. (Ed). Cholinesterase monographs in humans, genetics vol. 11 (1986), R.L. Basel, Switzerland 1-90
9. Bartels C.F., James K., and LaDu B.N. DNA mutations associated with the human butyrylcholinesterase J-variant. Am. J. Hum. Genet. 50 5 (1992) 1104-1114
10. Yen T., Nightingale B.N., Burns J.C., Sullivan D.R., and Stewart P.M. Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population. Clin. Chem. 49 8 (2003) 1297-1308
11. La Du B.N., Bartels C.F., Nogueira C.P., Hajra A., Lightstone H., vanderSpek A., et al. Phenotypic and molecular biological analysis of human butyrylcholinesterase variants. Clin. Biochem. 29 2 (1996) 165-169
12. Bartels C.F., Jensen F.S., Lockridge O., vanderSpek A.F., Rubinstein H.M., Lubrano T., et al. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am. J. Hum. Genet. 50 5 (1992) 1086-1103
13. Maekawa M., Kanno T., Sudo K., Akizuki S., and Magara T. Three different point mutations in the butyrylcholinesterase gene of three Japanese subjects with a silent phenotype: possible Japanese type alleles. Clin. Biochem. 29 2 (1996) 165-169
14. On-KeiChana A., Lamb C.W., Tongb S.F., Tungc C.M., Yungc K., Chand Y.W., et al. Novel mutations in the BCHE gene in patients with no butyrylcholinesterase activity. Clin. Chim. Acta 351 (2005) 155-159
15. Liua W., Chenga J., Iwasakia A., Imanishia H., and Hada T. Novel mutation and multiple mutations found in the human butyrylcholinesterase gene. Clin. Chim. Acta 326 (2002) 193-199
16. Nassar B.A., Darvesh S., Bevin L.D., Rockwood K., Kirkland S.A., O'Neill B.J., et al. Relation between butyrylcholinesterase K variant, paraoxonase 1 PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease. Clin. Biochem. 35 3 (2002) 205-209
17. Raygani A.V., Zahrai M., Solt Anzadeh A., Doosti M., Javadi E., and Pormotabbed T. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E phenotypes in Alzheimer's disease. Neurosci. Lett. 371 2-3 (2004) 142-146
18. Vahdati-Mashhadian N., Hassanzadeh M.K., Hosseini J., and Saffareshargh A.A. Ethnic differences in the frequency of distribution of serum cholinesterase activity in the Iranian population. Can. J. Physiol. Pharmacol. 82 5 (2004) 326-330
19. Lando G., Mosca A., Bonora R.M., Azzario F., Penco S., and Marocchi Am Panteghini M.C. Frequency of butyrylcholinesterase gene mutations in individuals with abnormal inhibition numbers: an Italian-population study. Pharmacogenetics 12 5 (2003) 265-270
20. Arnaud J., Brun R., Liobera R., and Constans J. serum cholinesterase polymorphism in France: an epidemiological survey of the deficient alleles detected by an automated micro-method. Ann. Hum. Biol. 18 1 (1991) 1-8
21. Ceppa F., Kenane N., Chellak S., Bigaillon C., and Burnat P. Prolonged succinylcholine-induced apnoea associated with cholinesterase silent plasma variant. Ann. Fr. Anesth. Reanim. 24 4 (2005) 425-427
22. Szeinberg A., Pipano S., Assa M., Medalie J.H., and Neuffld H.N. High frequency of atypical pseudocholinesterase gene among Iraq and Iranian Jews. Clin. Genet. 3 (1972) 127-1234
23. Garry P.J. A manual and automated procedure for measuring serum cholinesterase activity and identifying enzyme variants. Differentiation by means of Tris and phosphate buffers. Clin. Chem. 16 (1971) 183-191
24. Boutin D., and Brodeur J. An automated method for simultaneous determination of serum pseudocholinesterase activity, dibucaine number and fluoride number. Clin. Biochem. 23 5 (1990) 423-431
25. Hiossieni J., Firuzian F., and Feely J. Ethnic differences in the frequency distribution of serum cholinesterase activity in Iranian population. Ir. J. Med. Sci. 166 1 (1997) 10-12
26. Genc S., Gurdol F., Guvenc S., and Kargi Y. Variations in serum cholinesterase activity in different age and sex groups. Eur. J. Clin. Chem. Clin. Biochem. 35 3 (1997) 239-240
27. Singh S., Verma M., Leelamma C.O., Nain K., Goel R.C., Ganguly N.K., et al. Red cell acetylcholinesterase and plasma cholinesterase activity and genetic variants of plasma cholinesterase in northwest Indian adults. Int. J. Clin Pharmacol. Ther. 35 9 (1997) 357-360
28. Acuna M., Eaton L., Ramirez N.R., Cifuentes L., and Llop E. Genetic variants of serum butyrylcholinesterase in Chilean Mapuche Indians. Am. J. Phys. Anthropol. 121 1 (2003) 81-85
29. Levano S., Ginz H., Siegemund M., Filipovic M., Voronkov E., Urwyler A., et al. Genotyping the butyrylcholinesterase in patients with prolonged neuromuscular block after succinylcholine. Anesthesiology 102 3 (2005) 531-535
30. Rudolf V.S., Skrinjaric-Spoljar Z.K.M., and Evans R.T. An explanation for the different inhibitory characteristics of human serum butyrylcholinesterase phenotypes deriving from inhibition of atypical heterozygotes. Chem.-Biol. Interact. 119 (1999) 159-164
31. Flegar-Mestric Z.B., Surina B., and Sifar Z. Biological variations of human serum butyrylcholinesterase activity in population from Zagreb, Croatia. Chem.-Biol. Interact. 120 (1999) 193-199